National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 5/21/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

Genzyme Corporation;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

4/5/2013

Jessica Altman, MD

None

Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

8/14/2012

Frederick R. Appelbaum, MD

None

None

None

None

3/26/2013

Daniel A. Arber, MD

None

None

None

None

4/29/2013

Steven E. Coutre, MD

None

Genzyme Corporation

None

None

5/16/2013

Lloyd E. Damon, MD

None

None

None

None

2/19/2013

James M. Foran, MD

Eisai Inc.;
Genzyme Corporation;
Medarex, Inc.

Celgene Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

2/9/2010

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Salil Goorha, MD

None

None

None

None

3/7/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Jeffrey Lancet, MD

None

Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

8/6/2012

Lori J. Maness, MD

None

None

None

None

3/9/2012

Guido Marcucci, MD

None

None

None

None

8/15/2012

Peter Maslak, MD

None

None

None

None

10/14/2009

Joan S. McClure, MS

None

None

None

None

7/23/2012

Michael M. Millenson, MD, FACP

None

Amgen Inc.;
Celgene Corporation;
GlaxoSmithKline

None

None

2/22/2013

Joseph O. Moore, MD

None

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

8/24/2012

Margaret R. O'Donnell, MD

None

Celgene Corporation;
Eisai Inc.;
Genzyme Corporation

None

None

8/17/2011

Farhad Ravandi, MD

None

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

11/3/2012

Paul J. Shami, MD

None

Novartis Pharmaceuticals Corporation

JSK Therapeutics Inc.

None

1/28/2013

B. Douglas Smith, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

1/19/2013

Richard M. Stone, MD

None

Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
Merck & Co., Inc.

None

None

10/11/2011

Stephen A. Strickland, MD

None

Genzyme Corporation

None

None

3/25/2013

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/16/2012

Eunice S. Wang, MD

None

None

None

None

8/20/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved